Correction: Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR [Molecular and Cellular Biology, 32, 5 (2012) (929-940)] DOI: 10.1128/MCB.05921-11;Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR

Molecular and Cellular Biology

Volumn 32, Issue 5, 2012, Pages 929-940

  Gabai, Vladimir L ^a   Meng, Le ^a   Kim, Geunwon ^a   Mills, Teresa A ^a   Benjamin, Ivor J ^b   Sherman, Michael Y ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEAT SHOCK TRANSCRIPTION FACTOR 1; HUR PROTEIN; HYPOXIA INDUCIBLE FACTOR 1;

ADVANCED CANCER; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; HYPERPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RARE DISEASE; RNA BINDING; TUMOR GROWTH; XENOGRAFT;

EID: 84857169594     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00415-17     Document Type: Erratum

References (37)

1. Abdelmohsen K, Lal A, Kim HH, Gorospe M. 2007. Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 6:1288-1292.
2. Akalin A, et al. 2001. A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression. Cancer Res. 61:4791-4796.
3. Baird NA, Turnbull DW, Johnson EA. 2006. Induction of the heat shock pathway during hypoxia requires regulation of heat shock factor by hypoxia-inducible factor-1. J. Biol. Chem. 281:38675-38681.
4. Beere HM. 2005. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J. Clin. Invest. 115:2633-2639.
5. Ben-Porath I, Weinberg RA. 2005. The signals and pathways activating cellular senescence. Int. J. Biochem. Cell Biol. 37:961-976.
6. Bihani T, et al. 2004. Differential oncogenic Ras signaling and senescence in tumor cells. Cell Cycle 3:1201-1207.
7. Brahimi-Horn MC, Pouyssegur J. 2009. HIF at a glance. J. Cell Sci. 122:1055-1057.
8. Braig M, Schmitt CA. 2006. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res. 66:2881-2884.
9. Chang B-D, et al. 2002. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc. Natl. Acad. Sci. U. S. A. 99:389-394.
10. Chen R, Liliental JE, Kowalski PE, Lu Q, Cohen SN. 2011. Regulation of transcription of hypoxia-inducible factor-1alpha (HIF-1alpha) by heat shock factors HSF2 and HSF4. Oncogene 30:2570-2580.
11. Ciocca DR, Calderwood SK. 2005. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86-103.
12. Croce CM. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10:704-714.
13. Dai C, Whitesell L, Rogers AB, Lindquist S. 2007. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130:1005-1018.
14. Danilin S, et al. 2010. Role of the RNA-binding protein HuR in human renal cell carcinoma. Carcinogenesis 31:1018-1026.
15. Gabai VL, Mabuchi K, Mosser DD, Sherman MY. 2002. Hsp72 and stress kinase c-jun N-terminal kinase regulate the Bid-dependent pathway in tumor necrosis factor-induced apoptosis. Mol. Cell. Biol. 22:3415-3424.
16. Gabai VL, Yaglom JA, Waldman T, Sherman MY. 2009. Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells. Mol. Cell. Biol. 29:559-569.
17. Galban S, et al. 2008. RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol. Cell. Biol. 28:93-107.
18. Gordan JD, Simon MC. 2007. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr. Opin. Genet. Dev. 17:71-77.
19. Guy CT, et al. 1992. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. U. S. A. 89:10578 -10582.
20. Hunt CR, et al. 2004. Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3-deficient mice. Mol. Cell. Biol. 24:899-911.
21. Ke Q, Costa M. 2006. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 70:1469-1480.
22. Khaleque M, et al. 2005. Induction of heat shock proteins by heregulin beta1 leads to protection from apoptosis and anchorage-independent growth. Oncogene 24:6564-6573.
23. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M. 2008. A microRNA component of the hypoxic response. Cell Death Differ. 15:667-671.
24. Lopez de Silanes I, et al. 2003. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22:7146-7154.
25. Lopez de Silanes I, Lal A, Gorospe M. 2005. HuR: post-transcriptional paths to malignancy. RNA Biol. 2:11-13.
26. Lowe SW, Cepero E, Evan G. 2004. Intrinsic tumour suppression. Nature 432:307-315.
27. McMillan DR, Xiao X, Shao L, Graves K, Benjamin IJ. 1998. Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J. Biol. Chem. 273:7523-7528.
28. Meng L, Gabai VL, Sherman MY. 2010. Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene 29:5204-5213.
29. Meng L, Hunt C, Yaglom JA, Gabai VL, Sherman MY. 2011. Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. Oncogene 30:2836-2845.
30. Min J-N, Huang L, Zimonjic DB, Moskophidis D, Mivechi NF. 2007. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene 26:5086-5097.
31. Muller WJ, et al. 1996. Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Mol. Cell. Biol. 16:5726-5736.
32. Page TJ, et al. 2006. Genome-wide analysis of human HSF1 signaling reveals a transcriptional program linked to cellular adaptation and survival. Mol. Biosyst. 2:627-639.
33. Pirkkala L, Nykanen P, Sistonen L. 2001. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J. 15:1118-1131.
34. Semenza GL. 2010. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29:625-634.
35. Solimini NL, Luo J, Elledge SJ. 2007. Non-oncogene addiction and the stress phenotype of cancer cells. Cell 130:986-988.
36. Xiao X, et al. 1999. HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J. 18:5943-5952.
37. Zaarur NG, Porco VLJ, Calderwood S, Sherman M. 2006. Targeting heat shock response to sensitize cancer cell to proteasome and Hsp90 inhibitors. Cancer Res. 66:1783-1791.